Leerink previously estimated a $2.2 billion annual telehealth market if the FDA permitted all seven peptides reviewed in July ...

PRNewswire/ -- ("Glancy") announced today that the class action lawsuit covers investors who bought Hims & Hers Health, ...

Hims & Hers Health rises 3.86% today to $29.22 amid FTC complaint and class action news; near-term resistance remains.

Key TakeawaysHims & Hers shares rose 4% today after the company launched online weight-loss care for men in Germany. Germany suits Hims’ cash-pay model because statutory insurance there generally ...

The Law Offices of Howard G. Smith today reported that a securities class action lawsuit is pending against Hims & Hers Health, Inc. ("Hims ...

Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & ...

The June closing of the Eucalyptus acquisition transformed Hims & Hers Health (HIMS) into what the company now calls a global consumer health platform. Bears may be overlooking this shift. Investors ...

Hims & Hers Health stock slides 3.05% to $29.71 today after lawsuits, FTC complaints, and semaglutide withdrawal impact ...

NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: ...

Navigating male hair loss can be tricky, especially given the sea of over-the-counter and prescription treatments flooding ...

Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit ...

Shareholders who purchased shares of HIMS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not ...